News & events.

Our news.

Filter by Category
Filter by Year
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
News
June 10, 2021
2021

AbCellera Announces Secondary Private Sale of 11.9 Million Common Shares

Event
June 8, 2021
2021

MaRS Impact Health 2021

News
May 13, 2021
2021

AbCellera Reports Q1 2021 Business Results

News
May 11, 2021
2021

AbCellera to Present Virtually at Berenberg Conference on May 18, 2021

News
May 6, 2021
2021

AbCellera Partners with Angios to Develop Therapeutics to Combat Blindness Caused by Diabetic Retinopathy

News
May 4, 2021
2021

New AbCellera-Discovered Antibody that Neutralizes Viral Variants of COVID-19, LY-CoV1404, Enters Clinical Trials

News
April 29, 2021
2021

AbCellera Breaks Ground on Global Headquarters in Vancouver and Expects to Hire Hundreds of Scientific and Tech Professionals

News
April 21, 2021
2021

AbCellera to Report First Quarter 2021 Financial Results on May 13, 2021

News
April 14, 2021
2021

AbCellera and Empirico Announce Strategic Multi-Target Antibody Discovery Collaboration

News
April 12, 2021
2021

AbCellera to Present Virtually at Upcoming Investor Conferences